Disseminated fungal infection in a patient receiving zanubrutinib

Authors:

Abstract
Key Clinical Message: We report a case of fatal disseminated aspergillosis in the setting of administration of zanubrutinib, a second‐generation Bruton's tyrosine kinase inhibitor thought to have a lower rate of immunosuppression‐related side effects.
Funding Information
  • University of Iowa